Casodex (bicalutamide) coated tablets 150 mg. №28


Manufacturer: Italy



Casodex 150 mg is prescribed as monotherapy and as adjuvant therapy in combination with radical prostatectomy or radiotherapy for patients with locally advanced prostate cancer at high risk of disease progression (see Pharmacological Properties).
Casodex 150 mg is also prescribed for the treatment of patients with locally advanced non-metastatic prostate cancer when surgical castration or other medical interventions are unacceptable or cannot be used.